Amir Banihashemi, MD is a cytopathology pathology in Philadelphia, PA with 22 years of experience. The provider is a cytopathologist is an anatomic pathologist trained in the diagnosis of human disease by means of the study of cells obtained from body secretions and fluids, by scraping, washing, or sponging the surface of a lesion, or by the aspiration of a tumor mass or body organ with a fine needle. A major aspect of a cytopathologist's practice is the interpretation of Papanicolaou-stained smears of cells from the female reproductive systems, the Pap test. However, the cytopathologist's expertise is applied to the diagnosis of cells from all systems and areas of the body. He/she is a consultant to all medical specialists. Amir Banihashemi, MD NPI is 1891174165. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
3400 SPRUCE STREET
PHILADELPHIA, PA
ZIP 19104-206
Phone: (215) 662-6503
Fax: (215) 349-5910
The NPI 1891174165 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Special stained specimen slides to examine tissue (HCPCS:88341)
- Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
- Tissue or cell analysis by immunologic technique (HCPCS:88342)
- Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
- Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
The enumeration date for this NPI number is 5/20/2015 and was last updated on 11/3/2021.